1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow OOS-A regimen: new trials by email Literature Review of OOS-A regimen trials Research Report on OOS-A regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3) Regimen A, Regimen B, Regimen C - Hematological Malignancies | Phase 2 | Terminated | Medical University of South Carolina | 78 | 2010-06-01 | 2018-07-11 |
| Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma Regimen A, Regimen B - Lymphoma | Phase 2 | Completed | Northwestern University | 25 | 2007-02-06 | 2019-10-15 |
Burkitt Lymphoma (1) · Hematologic Neoplasms (1) · Lymphoma (1)
Medical University of South Carolina (1) · Northwestern University (1)
United States (2)
Leo Gordon, MD (1) · Robert Stuart, MD (1)
P30CA060553 (1)